Skip to main content
Equibles

STOREBRAND ASSET MANAGEMENT AS

Position in INCY — Incyte Corp

CIK 1685676 LYSAKER, Q8
Back to INCY Full portfolio

Position in INCY

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$8,941,610
+$1,340,950 QoQ
Shares Held
78,878
-2.3% QoQ
Ownership
0.039%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#177
of 855 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in INCY Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

STOREBRAND ASSET MANAGEMENT AS holds $199,901,062 across 11 Biotechnology names. INCY ranks #8 (4.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 107,628 $53,462,056
2 RPRX
Royalty Pharma plc
 703,962 $39,471,149
3 JAZZ
Jazz Pharmaceuticals plc
 109,183 $26,309,827
4 REGN
Regeneron Pharmaceuticals, Inc.
 38,479 $23,993,195
5 ALNY
Alnylam Pharmaceuticals, Inc.
 57,580 $17,333,307
6 RVMD
Revolution Medicines, Inc.
 80,251 $15,029,407
7 INSM
INSMED Inc
 124,848 $13,311,293
8 INCY
Incyte Corp
This page 		78,878 $8,941,610

All Filings in INCY

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $8,941,610 78,878
2026-03-31 $7,600,660 80,755
2025-12-31 $4,094,312 41,453
2025-09-30 $2,832,229 33,395
2025-06-30 $2,198,880 32,289
2025-03-31 $2,916,148 48,161
2024-12-31 $3,417,445 49,478
2024-09-30 $3,034,188 45,903
2024-06-30 $2,738,993 45,183
2024-03-31 $2,434,157 42,727
2023-12-31 $2,147,480 34,201
2023-09-30 $1,646,271 28,497
2023-06-30 $1,660,269 26,671
2023-03-31 $1,188,696 16,448
2022-12-31 $1,450,177 18,055
2022-09-30 $1,094,028 16,417
2022-06-30 $1,247,199 16,417
2022-03-31 $1,381,669 17,397
2021-12-31 $1,344,100 18,312
2021-09-30 $1,947,918 28,321
2021-06-30 $3,199,295 38,028
2021-03-31 $3,861,869 47,519
2020-12-31 $4,133,202 47,519
2020-09-30 $5,142,012 57,299
2020-06-30 $5,730,098 55,113
2020-03-31 $2,982,877 40,733